Claim OwnershipIn conversation with...
Subscribed: 26Played: 155
Subscribe
© 2023 The Lancet Group
Description
Peter Hayward, Editor-in-Chief of The Lancet HIV, speaks to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
58 Episodes
Reverse
Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancet
Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.Read the full article:The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea
Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade.Read the full article:The effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade
Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa. Read the full article:Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials
Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.Read the PopART trial papers:Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) communityImpact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa
Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.Read the full Review:HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men
Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.Read the full article:A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda
Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B. Read the full article:Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B
Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.Read the full article:Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya
Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.
Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV. Read the full article:Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV.
Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint The Lancet HIV and The Lancet Healthy Longevity Series Ageing with HIV.Read the Series:Ageing with HIV
Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa.
Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia. Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00186-7/fulltext
Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00240-X/fulltext
Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV. Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00156-9/fulltext
Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00148-X/fulltext
John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00103-X/fulltext
Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa. Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00005-9/fulltext
Comments
Download from Google Play
Download from App Store
United States